MMWR: Clinical Considerations for Use of PrEP Among Adolescents

Apr 29, 2020 | Kim Rodgers

CDC published a new analysis in Morbidity and Mortality Weekly Report (MMWR) that details key clinical considerations for providers prescribing PrEP for adolescents, including the latest safety data on PrEP for adolescents; legal issues about consent for clinical care and confidentiality in their respective states; the therapeutic partnership with adolescents and their parents or guardians; the need to tailor the clinical approach to enhance patient-provider communication; and trends in medication initiation, adherence, and persistence during adolescence.

View the article.


637020799465370000

About Kim Rodgers

Kim Rodgers is the Communications Manager at NACCHO.

More posts by Kim Rodgers

Related Posts

Toddlers outside i Stock 485737780
  • Tools & Resources
  • Healthy Living & Prevention
  • Parks

Greener Parks for Health

National Recreation and Park Association releases new Greener Parks for Health...

Jul 13, 2020

Greener Parks for Health

CDC QCS Graphic
  • Tools & Resources
  • Webinar
  • HIV, STI, & Viral Hepatitis

Informational Webinar: STD Quality Clinical Services...

Informational webinar for the STD QCS Planning Toolkit to Support Use of CDC’s...

Jul 13, 2020 | Rebekah Horowitz

Informational Webinar: STD Quality Clinical Services...

Webinar
  • Webinar
  • Immunization
  • Maternal, Child, & Adolescent Health

Webinar: Delays in HPV Cancer Diagnoses and Treatment in...

Residents of rural areas have a higher cancer mortality, particularly for...

Jul 10, 2020 | Kimberly Sharpe-Scott

Webinar: Delays in HPV Cancer Diagnoses and Treatment in...

COVID VC Screenshot
  • COVID-19
  • Tools & Resources
  • Emergency Response
  • Infectious Disease

NACCHO’s COVID-19 Virtual Community Now Available to All...

NACCHO has opened our COVID-19 Virtual Community to all local health department...

Jul 08, 2020 | Kim Rodgers

NACCHO’s COVID-19 Virtual Community Now Available to All...

Sync2020 logos horizontal 1024x304
  • HIV, STI, & Viral Hepatitis

Scholarships Available: SYNChronicity 2020 Conference –...

SYNC 2020, the National Conference for HIV, HCV, STI and LGBTQ Health, is...

Jul 08, 2020 | Julia Zigman

Scholarships Available: SYNChronicity 2020 Conference –...

  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Kaiser Family Foundation: Reduction in Sexual and...

The Kaiser Family Foundation released a new issue brief, Potential Impacts of...

Jul 08, 2020 | Julia Zigman

Kaiser Family Foundation: Reduction in Sexual and...

2000px US CDC logo
  • HIV, STI, & Viral Hepatitis

New Recommendations for Hepatitis Vaccination

CDC has released new recommendations for hepatitis A virus (HAV) vaccination,...

Jul 08, 2020 | Julia Zigman

New Recommendations for Hepatitis Vaccination

TAG Logo
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Treatment Action Group 2020 Pipeline Report Now Available

Treatment Action Group (TAG) recently published their 2020 Pipeline Report, an...

Jul 08, 2020 | Julia Zigman

Treatment Action Group 2020 Pipeline Report Now Available

Pr EP injectable
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

New Study: Injectable PrEP is Safe and Highly Effective

New data further shows an injectable antiretroviral for HIV pre-exposure...

Jul 08, 2020 | Julia Zigman

New Study: Injectable PrEP is Safe and Highly Effective

Back to Top